Press "esc" to clear
Go to Advanced Search

Showing results

6170 of 2921
CardiologyTeam_2_crop.jpg

Article ID: 688337

Cardiology Appointments Enhance NYU Langone Heart Program in Brooklyn

NYU Langone Hospital - Brooklyn

NYU Langone Hospital – Brooklyn has appointed four highly skilled heart specialists to integrate new technology and advances in research with the care delivered in the community.

Released:
23-Jan-2018 12:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Add Images
or Multimedia

Article ID: 688279

Researchers Borrow from AIDS Playbook to Tackle Rheumatic Heart Disease: Taking Services to the People

Case Western Reserve University

Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the investments and lessons learned from HIV could be used to improve care for those with other serious chronic conditions? With this question in mind, researchers from Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, along with investigators and clinicians based in Uganda, borrowed an HIV/AIDS innovation to seek inroads against rheumatic heart disease in sub-Saharan Africa.

Released:
22-Jan-2018 2:55 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment
Linda-Shore-Lesserson.png
  • Embargo expired:
    19-Jan-2018 5:00 PM EST

Article ID: 687895

New Clinical Practice Guideline Addresses Use of Blood Thinners During Heart Surgery

The Society of Thoracic Surgeons

The Society of Thoracic Surgeons (STS), the Society of Cardiovascular Anesthesiologists (SCA), and the American Society of ExtraCorporeal Technology (AmSECT) released a new clinical practice guideline that includes major recommendations for the use of blood thinning medication (anticoagulants) during heart surgery.

Released:
12-Jan-2018 9:55 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Add Images
or Multimedia

Article ID: 667700

Neurogastronomy, After Surgical Weight Loss, Probiotic Akkermansia and More in the Obesity News Source

Newswise

Click here to go directly to Newswise's Obesity News Source

Released:
19-Jan-2018 3:35 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Aging, Alcohol and Alcoholism, Alternative Medicine, Asthma, Autoimmune Diseases, Behavioral Science, Cardiovascular Health, Cell Biology, Chemistry, Complementary Medicine, Digestive Disorders, Emergency Medicine, Environmental Health, Exercise and Fitness, Family and Parenting, Food and Water Safety, Food Science, Heart Disease, Kidney Disease, Men's Healt

CRFWHHIMini-MedSchoolFebruarySeminar-1.jpg

Article ID: 688157

CRF Invites the NYC Community to Attend Free Seminar on the Link Between Diabetes and Heart Disease During American Heart Month

Cardiovascular Research Foundation (CRF)

The Cardiovascular Research Foundation (CRF) will hold a free seminar, “The Link Between Diabetes & Your Heart,” on Wednesday, February 7, 2018 in New York City. The seminar, part of a series of Mini-Med School seminars conducted by the CRF Women’s Heart Health Initiative, will focus on providing attendees a deeper understanding of diabetes and its connection with cardiovascular disease.

Released:
18-Jan-2018 2:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cardiovascular Health, Diabetes, Heart Disease, Local - New York, Local - New York Metro

Add Images
or Multimedia

Article ID: 688134

Researchers Discover New Enzymes Central to Cell Function

Case Western Reserve University

Doctors have long treated heart attacks, improved asthma symptoms, and cured impotence by increasing levels of a single molecule in the body: nitric oxide. The tiny molecule can change how proteins function. But new research featured in Molecular Cell suggests supplementing nitric oxide—NO—is only the first step. Researchers have discovered previously unknown enzymes in the body that convert NO into “stopgap” molecules—SNOs—that then modulate proteins. The newly discovered enzymes help NO have diverse roles in cells. They may also be prime therapeutic targets to treat a range of diseases.

Released:
18-Jan-2018 12:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment
michigan-med-l-chronic-care-01.jpg

Article ID: 687954

In Chronic Disease Care, Family Helpers Are Key, But Feel Left Out

Michigan Medicine - University of Michigan

People with diabetes, heart failure and other chronic diseases often live independent lives, without a traditional caregiver. But many have a family member or friend who plays a key supporting role in their health care.

Released:
16-Jan-2018 9:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Arthritis, Cardiovascular Health, Diabetes, Healthcare

michigan-med-l-ed-heart-01.jpg

Article ID: 687938

New Blood Test for Diagnosing Heart Attacks: A ‘Big Deal,’ with Caveats

Michigan Medicine - University of Michigan

A longtime blood test that measures the likelihood of a cardiac event has become more sensitive and more precise. Why doctors and patients should be cautiously optimistic.

Released:
15-Jan-2018 3:30 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cardiovascular Health, Healthcare, Heart Disease, JAMA, All Journal News

Add Images
or Multimedia

Article ID: 687934

Insurance Company Requirements Place Heavy Administrative Burden on Physicians Seeking to Prescribe New Cholesterol-Lowering Drugs

Perelman School of Medicine at the University of Pennsylvania

A rare glimpse into the prior authorization requirements implemented by public and private insurance providers across the country has found substantial administrative burden for a new class of medications for patients with high cholesterol that places them at high risk for heart attack or stroke. So-called proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are self-injected medications approved for individuals with a genetic condition called familial hypercholesterolemia (FH) and those with atherosclerotic cardiovascular disease (ASCVD) who have high cholesterol despite receiving traditional statin medications and other treatments. Results of the study are published in Circulation: Cardiovascular Quality and Outcomes.

Released:
15-Jan-2018 11:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Blood Disorders, Cardiovascular Health, Heart Disease, Healthcare, Pharmaceuticals, Local - Pennsylvania

Article ID: 687794

Heart-Muscle Patches Made with Human Cells Improve Heart Attack Recovery

University of Alabama at Birmingham

Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.

Released:
10-Jan-2018 3:45 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cardiovascular Health, Engineering, All Journal News, Grant Funded News


Showing results

6170 of 2921





Chat now!